We are live on ! Find out more
Belvedere Trading

Belvedere Trading Portfolio holdings

AUM $87.6B
1-Year Est. Return 131.08%
This Fund
S&P 500
This Quarter Est. Return
+3.34%
1 Year Est. Return
+131.08%
3 Year Est. Return
+497.29%
5 Year Est. Return
+787.25%
10 Year Est. Return
AUM
$3.82B
AUM Growth
+$2.48B
Cap. Flow
+$2.44B
Cap. Flow %
63.89%
Top 10 Hldgs %
92.79%
Holding
683
New
348
Increased
67
Reduced
55
Closed
206

Sector Composition

Rank Sector Weight
1 Technology 4.25%
2 Consumer Discretionary 0.64%
3 Healthcare 0.37%
4 Industrials 0.21%
5 Financials 0.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REUN
451
PUT
DELISTED
Reunion Neuroscience Inc. Common Shares
REUN
$17K ﹤0.01%
+540
New +$13.6K
AEVA
452
PUT
Aeva Technologies
AEVA
$1.26B
$15K ﹤0.01%
+400
New +$18.6K
PAVM icon
453
PAVmed
PAVM
$39.4M
$15K ﹤0.01%
+5
New +$15.8K
XONE
454
PUT
DELISTED
The ExOne Company
XONE
$15K ﹤0.01%
+700
New +$14.7K
SB icon
455
CALL
Safe Bulkers
SB
$803M
$14K ﹤0.01%
+2,900
New +$11.2K
MSON
456
CALL
DELISTED
Misonix Inc
MSON
$13K ﹤0.01%
+500
New +$12.4K
FIRY
457
PUT
Firy Inc
FIRY
$144M
$12K ﹤0.01%
70
-200
-74% -$51.7K
SRTA
458
Strata Critical Medical Inc
SRTA
$480M
$11K ﹤0.01%
+1,085
New +$9.48K
EEM icon
459
PUT
iShares MSCI Emerging Markets ETF
EEM
$28.9B
$10K ﹤0.01%
+200
New +$10.4K
OPAD icon
460
Offerpad Solutions
OPAD
$17.3M
$10K ﹤0.01%
+8
New +$12.3K
WWR icon
461
PUT
Westwater Resources
WWR
$55M
$10K ﹤0.01%
+3,000
New +$11.7K
PTGX icon
462
PUT
Protagonist Therapeutics
PTGX
$8.51B
$9K ﹤0.01%
+300
New +$12.8K
GRN icon
463
PUT
iPath Series B Carbon Exchange-Traded Notes
GRN
$23.5M
$7K ﹤0.01%
300
+200
+200% +$4.51K
OPEN icon
464
PUT
Opendoor
OPEN
$3.8B
$7K ﹤0.01%
+310
New +$5.01K
CUK
465
DELISTED
Carnival PLC
CUK
$5K ﹤0.01%
+243
New +$5.16K
RDHL
466
Redhill Biopharma
RDHL
$3.95M
$4K ﹤0.01%
+1
New +$6.78K
RXRX icon
467
PUT
Recursion Pharmaceuticals
RXRX
$1.69B
$4K ﹤0.01%
+200
New +$5.67K
BMRA icon
468
PUT
Biomerica
BMRA
$4.73M
$3K ﹤0.01%
+75
New +$2.47K
LFWD icon
469
ReWalk Robotics
LFWD
$20.3M
$3K ﹤0.01%
+28
New +$3.48K
CRDF icon
470
Cardiff Oncology
CRDF
$72.7M
$2K ﹤0.01%
+332
New +$2.09K
SJB icon
471
PUT
ProShares Short High Yield
SJB
$47.8M
$2K ﹤0.01%
+100
New +$1.78K
ENDP
472
DELISTED
Endo International plc
ENDP
$2K ﹤0.01%
+387
New +$1.37K
AAL icon
473
American Airlines Group
AAL
$10.6B
-9,219
Closed -$190K
AAL icon
474
PUT
American Airlines Group
AAL
$10.6B
-7,200
Closed -$148K
ABTS icon
475
Abits Group
ABTS
$3.05M
-27,384
Closed -$11.2M

Similar funds

Belvedere Trading's Q3 2021 Portfolio in Review

As of Q3 2021, Belvedere Trading held 683 positions worth $3.82B, up 184% from $1.34B the previous quarter. Its ten largest holdings account for 93% of the portfolio.

Belvedere Trading deployed $2.44B of net new capital in Q3 2021, opening 348 new positions and adding to 67 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 192,540 shares worth $86.1M.

By sector, the portfolio is most concentrated in Technology at 4.2% of assets, down from 7.6% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Amazon, an estimated $30.5M trimmed.

  • Belvedere Trading's largest Q3 2021 buy was State Street SPDR S&P 500 ETF Trust: 192,540 shares worth $86.1M.
  • Belvedere Trading added most to Apple in Q3 2021, an estimated $57.7M increase.
  • Belvedere Trading's biggest Q3 2021 reduction was Amazon, cutting an estimated $30.5M.
  • Belvedere Trading fully exited Tesla in Q3 2021, selling an estimated $12.5M.
  • Belvedere Trading's ten largest holdings make up 93% of its $3.82B portfolio in Q3 2021.
  • Belvedere Trading opened 348 new positions and closed 206 in Q3 2021.
  • Belvedere Trading's portfolio value rose 184% quarter-over-quarter to $3.82B.

Based on Belvedere Trading's 13F filing for Q3 2021, filed 19 Oct 2021.